New Triple-Threat treatment trial aims to shrink rectal tumors before surgery
NCT ID NCT07297030
Summary
This study is testing a new combination treatment for people with high-risk, locally advanced rectal cancer. The goal is to see if a shorter, more intense course of radiation, given alongside chemotherapy and an immunotherapy drug, can shrink tumors more effectively before surgery. Researchers will measure how many patients have their cancer completely disappear and monitor the safety of this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of colorectal surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.